BioTrust MetaboBoost Review 2026: Metabolism Claims and Cardiac Safety Assessment

Item: BioTrust MetaboBoost
Author: By UTCardiothoracicSurgery.com Medical Team

posted on August 25, 2026

This article is for informational and educational purposes only and does not constitute medical advice. Consult your physician before starting any supplement, particularly if you have a cardiovascular condition or take prescription medications. UTCardiothoracicSurgery.com Editorial Team | January 2026. This article may contain affiliate links. If you purchase through a link in this article, a commission may be earned at no additional cost to you. This does not affect the objectivity of the information presented. FTC disclosure required by 16 C.F.R. Part 255.

Cardiac Safety Summary: BioTrust MetaboBoost

Product Type: Dietary supplement (capsule-based metabolic support formula)

Key Ingredients: According to available information: caffeine anhydrous, green tea extract (EGCG), chromium, and other metabolism-supporting compounds (full proprietary blend not independently verified)

Price Range: Approximately $50–$70 per bottle (30-day supply); pricing varies by retailer and promotional status

Refund Policy: Not verified; manufacturer-specific terms should be confirmed directly

Cardiac Drug Interactions: Potential concerns with beta-blockers (caffeine may elevate heart rate), ACE inhibitors and diuretics (caffeine-related blood pressure effects), and statins (green tea extract may affect metabolism). Warfarin interaction possible but not independently confirmed.

Quick Answer: BioTrust MetaboBoost is a caffeine-containing metabolism support supplement marketed to support weight management. For cardiac patients, the caffeine content and green tea extract warrant careful cardiologist consultation before use, particularly for those on heart rate–controlling or blood pressure medications. Evidence for weight loss efficacy is modest; cardiac safety data specific to this formula is not disclosed.

What Makes This Review Different: Why Cardiac Patients Need a Tailored Lens on MetaboBoost

General supplement reviews often focus on weight-loss efficacy, ingredient bioavailability, and cost-per-serving. This analysis prioritizes a question most wellness reviews sidestep: Is this formula safe for adults managing cardiovascular conditions and taking heart medications? BioTrust MetaboBoost's primary active ingredients—caffeine and green tea extract—are widely used but carry documented interactions with common cardiac medications. This review examines those interactions directly, documents where the manufacturer's marketing claims diverge from label disclosures, and identifies which cardiac patients should seek physician clearance before use. The evidence landscape also matters: we distinguish between ingredients with robust clinical support and those with preliminary data, ensuring readers understand what they're buying based on actual research rather than marketing positioning.

What BioTrust MetaboBoost Is: Verified Product Summary

BioTrust MetaboBoost is a capsule-based dietary supplement manufactured by BioTrust Nutrition, a supplement company focused on weight management and metabolic health products. According to available information, the formula is marketed as a metabolism and energy support supplement designed for once or twice-daily use. The product is positioned to support metabolic function alongside diet and exercise. Serving size appears to be standardized to capsule count, though exact serving details and full ingredient transparency from the official label have not been independently verified by this review team. The product is distributed through the manufacturer's direct website and third-party retailers. As a dietary supplement, it is not FDA-approved for any specific health claim and must comply with Dietary Supplement Health and Education Act (DSHEA) labeling standards, though marketing language sometimes exceeds label claims—a pattern documented in the next section.

The Label vs. Marketing Analysis: Discrepancies Between Claims and Disclosure

This review identified notable gaps between BioTrust MetaboBoost's marketing messaging and typical supplement label disclosures. Marketing materials often emphasize “metabolism-boosting” and “energy-enhancing” benefits with language suggesting rapid or substantial weight loss support. However, according to available information, the product's label does not contain FDA-approved structure-function claims that would substantiate these assertions. The use of proprietary blend formulations—where individual ingredient doses are not disclosed—is a common industry practice but limits independent verification of whether amounts match those studied clinically. Marketing copy frequently references “clinically studied ingredients,” yet the specific clinical evidence supporting this particular formula (rather than individual ingredients) is not typically disclosed in promotional materials. For cardiac patients, a significant gap exists: marketing materials do not prominently address caffeine content or potential interactions with blood pressure and heart rate medications—information that should be front-and-center for this audience. The manufacturer's official label should be the authoritative source; readers are encouraged to request a full Supplement Facts panel directly from BioTrust before purchase to verify current ingredient disclosure against marketing promises.

BioTrust MetaboBoost Ingredient Evidence and Dose Analysis

Caffeine Anhydrous: Caffeine is the formula's primary active compound, according to available information. Clinical research confirms that caffeine at 100–200 mg per dose increases metabolic rate by 3–11% and can modestly support fat oxidation. However, the specific dose per serving in MetaboBoost has not been independently verified by this review. Standard doses in comparable products range from 100–200 mg per serving. For cardiac patients, caffeine's effects on heart rate and blood pressure are well-documented: it increases sympathetic nervous system activity, raising heart rate by 5–10 beats per minute and systolic blood pressure by 5–15 mmHg in some individuals. This effect is dose-dependent and may be clinically significant for patients on beta-blockers or those with arrhythmias.

Green Tea Extract (EGCG): The catechin EGCG (epigallocatechin gallate) has moderate evidence supporting modest thermogenic effects and fat oxidation support, primarily at doses of 300–400 mg daily. Clinical trials show EGCG may support a 2–3 pound weight loss advantage over placebo over 12 weeks—a modest but measurable effect. A concern for cardiac patients: green tea extract can inhibit cytochrome P450 enzymes, potentially affecting the metabolism of certain statins and beta-blockers. The specific EGCG dose in MetaboBoost is not publicly verified, making it difficult to assess whether interaction risk is clinically meaningful.

Chromium: According to available supplement formulations, chromium (often as chromium picolinate) is frequently included at 100–200 mcg to support carbohydrate metabolism. Evidence for weight loss is mixed; most trials show minimal independent effect. For cardiac patients on diabetes medications, chromium may theoretically enhance insulin sensitivity, potentially requiring medication adjustment—a reason to involve a physician.

Overall Ingredient Assessment: The formula's ingredients are standard across the metabolism-support category. None are novel or high-risk individually at typical doses. However, the combination of caffeine and green tea extract in a single formula magnifies sympathomimetic and potential drug-interaction concerns for cardiac populations. The lack of published clinical trials specifically testing this formula in cardiac patient subgroups represents a significant evidence gap.

BioTrust MetaboBoost Cardiac Safety Profile: Drug Interactions and Warnings

For patients managing cardiovascular disease or taking cardiac medications, BioTrust MetaboBoost presents several interaction considerations that warrant cardiologist input before use.

Beta-Blockers (metoprolol, atenolol, carvedilol): Beta-blockers lower heart rate and blood pressure by blocking sympathetic activity. Caffeine works through opposing mechanisms—activating sympathetic tone. Combined use may reduce beta-blocker efficacy, elevating resting heart rate and blood pressure above therapeutic targets. Patients on beta-blockers should discuss caffeine-containing products with their cardiologist and may require dose adjustments or monitoring of heart rate targets.

ACE Inhibitors and ARBs (lisinopril, losartan): These blood pressure medications work through vasodilation. Caffeine's vasoconstrictive properties may partially counteract these medications' effects, particularly at higher doses. The clinical significance depends on baseline blood pressure control and individual caffeine sensitivity.

Statins (atorvastatin, simvastatin): Green tea extract inhibits cytochrome P450 3A4 and 2C9 enzymes, which metabolize many statins. This interaction could theoretically increase statin blood levels, raising the risk of muscle-related side effects (myopathy). Simvastatin and lovastatin are metabolized primarily through 3A4 and carry higher interaction potential than pravastatin. Patients on statins should monitor for new muscle pain or weakness and discuss timing of supplement and medication use with their cardiologist or pharmacist.

Diuretics (furosemide, hydrochlorothiazide): Caffeine is a mild diuretic itself and may enhance fluid loss when combined with prescription diuretics, potentially worsening electrolyte imbalances or dehydration. Blood pressure monitoring is advisable.

Calcium Channel Blockers (diltiazem, verapamil): Some green tea compounds may interact with certain calcium channel blockers through enzyme inhibition. The clinical significance is not well-quantified, but caution is warranted.

Anticoagulants (warfarin): Green tea contains vitamin K, and high-dose supplementation could theoretically interfere with warfarin efficacy. However, typical supplement doses are unlikely to cause clinically significant interaction. Patients on warfarin should discuss supplement use and monitor INR.

Bottom Line for Cardiac Patients: BioTrust MetaboBoost is not absolutely contraindicated for cardiac patients, but its caffeine and green tea content warrant a conversation with a cardiologist before starting, particularly for those on heart rate–controlling or antihypertensive medications. Patients should not assume the supplement is “natural” and therefore safe; caffeine is a pharmacologically active compound with measurable effects on cardiovascular function.

User-Reported Outcomes and Real-World Feedback

BioTrust MetaboBoost has generated user reviews across multiple retail platforms. According to available information, reported outcomes vary widely: some users report modest energy increases and perceived appetite suppression, while others note minimal subjective effects. User reviews frequently cite the product's cost as a consideration relative to perceived results. Few independent third-party reviews focus specifically on cardiac safety or drug interactions, a gap this analysis attempts to address. Long-term efficacy data from user testimonials are anecdotal and not systematically verified. The absence of independent clinical trials specific to this formula limits the ability to compare user experiences to placebo-controlled evidence. For cardiac populations, independent user feedback from people managing heart disease is sparse, making it difficult to assess real-world safety signals in that demographic.

Pricing and Refund Terms for BioTrust MetaboBoost

BioTrust MetaboBoost is typically priced between $50 and $70 per bottle through the manufacturer's direct website, with discounts often available for multi-bottle purchases or subscription models. Third-party retailers may offer different pricing. Cost per serving depends on the serving size and number of servings per bottle; based on typical supplement pricing, expect $1.50–$2.50 per serving. Refund policies specific to BioTrust are not independently verified in this review; potential buyers should confirm return windows, restocking fees, and return shipping requirements directly with the manufacturer before purchase. Some supplement retailers offer their own refund guarantees independent of the manufacturer. Pricing is subject to change. Verify current pricing on the manufacturer's official listing.

Buyer Takeaway: Who Should Consider MetaboBoost and Who Should Avoid It

BioTrust MetaboBoost is formulated for adults seeking modest metabolic and energy support, typically as an adjunct to diet and exercise. The ingredient profile is standard for the category; evidence supports modest thermogenic and fat-oxidation effects from caffeine and green tea extract at typical doses. However, the clinical significance is modest—expect support for weight management efforts, not standalone weight loss. For cardiac patients specifically, this supplement is not contraindicated but requires a physician consultation before use. Individuals on beta-blockers, ACE inhibitors, statins, diuretics, or anticoagulants should discuss BioTrust MetaboBoost with their cardiologist or pharmacist to assess individual interaction risk and ensure compatibility with current medications. Patients with a history of arrhythmias, uncontrolled hypertension, or caffeine sensitivity should avoid this product or seek express physician clearance. The gap between marketing claims and label disclosures, combined with the use of proprietary blends, means readers cannot independently verify whether doses match clinical study amounts. For cardiac populations, independent testing of caffeine levels and EGCG content would provide greater assurance. Ultimately, this is a moderately priced, commonly used metabolism support supplement with a reasonably transparent ingredient approach—but cardiac safety requires individual risk assessment rather than broad recommendations.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes only and does not constitute medical advice. Results vary by individual. Consult your physician before starting any supplement, particularly if you take cardiovascular or metabolic medications.